Huda Y Zoghbi
Director at Regeneron Pharmaceuticals, Inc. (REGN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.9M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 12SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 800 | $800.00 | $640K | -9.2% |
| Feb 23SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 49 | $774.68 | $38K | -6.2% |
| Feb 23SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 50 | $775.50 | $39K | -6.3% |
| Feb 23SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 53 | $778.47 | $41K | -6.7% |
| Feb 23SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 208 | $779.55 | $162K | -6.8% |
| Feb 23SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 331 | $780.45 | $258K | -6.9% |
| Feb 23SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 209 | $781.28 | $163K | -7.0% |
| Feb 23SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 298 | $782.10 | $233K | -7.1% |
| Feb 23SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 220 | $783.29 | $172K | -7.3% |
| Feb 23SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 160 | $784.45 | $126K | -7.4% |
| Feb 23SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 56 | $785.61 | $44K | -7.5% |
| Feb 23SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 4 | $790.00 | $3K | -8.0% |
- Sell
Director Huda Y Zoghbi sold $640K of REGN at $800.00 — cuts the stake by 32%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Huda Y Zoghbi sold $38K of REGN at $774.68 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Huda Y Zoghbi sold $39K of REGN at $775.50 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Huda Y Zoghbi sold $41K of REGN at $778.47 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Huda Y Zoghbi sold $162K of REGN at $779.55 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Huda Y Zoghbi sold $258K of REGN at $780.45 — pre-scheduled 10b5-1 plan sale.